Genetic control of susceptibility to candida albicans in SM/J mice

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1290-1300

  Radovanovic, Irena ^a   Leung, Vicki ^a   Iliescu, Alexandra ^a   Bongfen, Silayuv E ^a   Mullick, Alaka ^b   Langlais, David ^a   Gros, Philippe ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN LY6G; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; C57BL 6 MOUSE; CANDIDA ALBICANS; CANDIDIASIS; CARG5 GENE; CELL POPULATION; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 15; CHROMOSOME REPLICATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; HYBRID MOUSE STRAIN; IMMUNOPHENOTYPING; INFECTION SENSITIVITY; MALE; MONOCYTE; MOUSE; MOUSE STRAIN; MYELOID INFLAMMATORY SCORE; NEUTROPHIL; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; RNA SEQUENCE; SCORING SYSTEM; SM J MOUSE;

ANIMALS; ANTIGENS, LY; CANDIDIASIS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; IMMUNOPHENOTYPING; INFLAMMATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED A; MICE, INBRED C57BL; MONOCYTES; NEUTROPHILS; PRIMARY CELL CULTURE; REPRESSOR PROTEINS; SPECIES SPECIFICITY; SPORES, FUNGAL;

EID: 84906087061     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400783     Document Type: Article

References (93)

1. Mathews, H. L., and L. Witek-Janusek. 2002. Host defense against oral, esophageal, and gastrointestinal candidiasis. In Candida and Candidiasis. R. A. Calderone, ed. ASM Press, Washington, DC, p. 179-192.
2. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39: 309-317.
3. Holland, S. M., F. R. DeLeo, H. Z. Elloumi, A. P. Hsu, G. Uzel, N. Brodsky, A. F. Freeman, A. Demidowich, J. Davis, M. L. Turner, et al. 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357: 1608-1619.
4. van de Veerdonk, F. L., T. S. Plantinga, A. Hoischen, S. P. Smeekens, L. A. B. Joosten, C. Gilissen, P. Arts, D. C. Rosentul, A. J. Carmichael, C. A. A. Smits-van der Graaf, et al. 2011. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365: 54-61.
5. Puel, A., S. Cypowyj, J. Bustamante, J. F. Wright, L. Liu, H. K. Lim, M. Migaud, L. Israel, M. Chrabieh, M. Audry, et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332: 65-68.
6. Glocker, E. O., A. Hennigs, M. Nabavi, A. A. Schäffer, C. Woellner, U. Salzer, D. Pfeifer, H. Veelken, K. Warnatz, F. Tahami, et al. 2009. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361: 1727-1735.
7. Rodriguez-Gallego, J. C., M. Ouederni, S. Boisson-Dupuis, A. Puel, C. Picard, I. Sologuren, J. Bustamante, A. Samarina, E. Herrera-Ramos, M. Lopez-Rodriguez, et al. 2012. Clinical features of Candidiasis in patients with interleukin-12 receptor b1 deficiency. J. Clin. Immunol. 32: 305-305.
8. Lanternier, F., S. Pathan, Q. Vincent, L. Liu, S. Cypowij, C. Prando, M. Migaud, L. Taibi, A. Ammar-Khodja, O. B. Stambouli, et al. 2012. Human invasive dermatophytic disease is caused by inborn errors of CARD9. J. Clin. Immunol. 32: 94.
9. Ouederni, M., O. Sanal, A. Ikinciogullari, I. Tezcan, F. Dogu, I. Sologuren, S. Pedraza-Sánchez, M. Keser, G. Tanir, C. Nieuwhof, et al. 2014. Clinical features of Candidiasis in patients with inherited interleukin 12 receptor b1 deficiency. Clin. Infect. Dis. 58: 204-213.
10. Tuite, A., M. Elias, S. Picard, A. Mullick, and P. Gros. 2005. Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice. Genes Immun. 6: 672-682.
11. Tsoni, S. V., A. M. Kerrigan, M. J. Marakalala, N. Srinivasan, M. Duffield, P. R. Taylor, M. Botto, C. Steele, and G. D. Brown. 2009. Complement C3 plays an essential role in the control of opportunistic fungal infections. Infect. Immun. 77: 3679-3685.
12. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
13. Held, K., S. Thiel, M. Loos, and F. Petry. 2008. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans. Mol. Immunol. 45: 3934-3941.
14. Hector, R. F., J. E. Domer, and E. W. Carrow. 1982. Immune responses to Candida albicans in genetically distinct mice. Infect. Immun. 38: 1020-1028.
15. Morelli, R., and L. T. Rosenberg. 1971. The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. J. Immunol. 107: 476-480.
16. Mullick, A., M. Elias, S. Picard, L. Bourget, O. Jovcevski, S. Gauthier, A. Tuite, P. Harakidas, C. Bihun, B. Massie, and P. Gros. 2004. Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infect. Immun. 72: 5868-5876.
17. Pfaller, M. A., and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20: 133-163.
18. Neofytos, D., K. Lu, A. Hatfield-Seung, A. Blackford, K. A. Marr, S. Treadway, D. Ostrander, V. Nussenblatt, and J. Karp. 2013. Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy. Diagn. Microbiol. Infect. Dis. 75: 144-149.
19. Davis, S. L., E. P. Hawkins, E. O. Mason, Jr., C. W. Smith, and S. L. Kaplan. 1996. Host defenses against disseminated candidiasis are impaired in intercellular adhesion molecule 1-deficient mice. J. Infect. Dis. 174: 435-439.
20. Balish, E., R. D. R. Wagner, A. Vazquez-Torres, J. Jones-Carson, C. Pierson, and T. Warner. 1999. Mucosal and systemic candidiasis in IL-8Rh-/-BALB/c mice. J. Leukoc. Biol. 66: 144-150.
21. Segal, B. H., T. L. Leto, J. I. Gallin, H. L. Malech, and S. M. Holland. 2000. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79: 170-200.
22. Metzler, K. D., T. A. Fuchs, W. M. Nauseef, D. Reumaux, J. Roesler, I. Schulze, V. Wahn, V. Papayannopoulos, and A. Zychlinsky. 2011. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 117: 953-959.
23. Vinh, D. C., S. Y. Patel, G. Uzel, V. L. Anderson, A. F. Freeman, K. N. Olivier, C. Spalding, S. Hughes, S. Pittaluga, M. Raffeld, et al. 2010. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 115: 1519-1529.
24. Hsu, A. P., E. P. Sampaio, J. Khan, K. R. Calvo, J. E. Lemieux, S. Y. Patel, D. M. Frucht, D. C. Vinh, R. D. Auth, A. F. Freeman, et al. 2011. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118: 2653-2655.
25. Hambleton, S., S. Salem, J. Bustamante, V. Bigley, S. Boisson-Dupuis, J. Azevedo, A. Fortin, M. Haniffa, L. Ceron-Gutierrez, C. M. Bacon, et al. 2011. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365: 127-138.
26. Lionakis, M. S., J. K. Lim, C.-C. R. Lee, and P. M. Murphy. 2011. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J. Innate. Immun. 3: 180-199.
27. Ngo, L. Y., S. Kasahara, D. K. Kumasaka, S. E. Knoblaugh, A. Jhingran, and T. M. Hohl. 2014. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J. Infect. Dis. 209: 109-119.
28. Wetsel, R. A., D. T. Fleischer, and D. L. Haviland. 1990. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 59-exon. J. Biol. Chem. 265: 2435-2440.
29. Radovanovic, I., A. Mullick, and P. Gros. 2011. Genetic control of susceptibility to infection with Candida albicans in mice. PLoS ONE 6: e18957.
30. Ashman, R. B., E. M. Bolitho, and J.M. Papadimitriou. 1993. Patterns of resistance to Candida albicans in inbred mouse strains. Immunol. Cell Biol. 71: 221-225.
31. Ashman, R. B., A. Fulurija, and J. M. Papadimitriou. 1996. Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load. Infect. Immun. 64: 1866-1869.
32. Ashman, R. B. 1998. A gene (Carg1) that regulates tissue resistance to Candida albicans maps to chromosome 14 of the mouse. Microb. Pathog. 25: 333-335.
33. Ashman, R. B., A. Fulurija, and J. M. Papadimitriou. 1998. A second Candida albicans resistance gene (Carg2) regulates tissue damage, but not fungal clearance, in sub-lethal murine systemic infection. Microb. Pathog. 25: 349-352.
34. Fortin, A., E. Diez, D. Rochefort, L. Laroche, D. Malo, G. A. Rouleau, P. Gros, and E. Skamene. 2001. Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics 74: 21-35.
35. Haley, C. S., and S. A. Knott. 1992. A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity (Edinb) 69: 315-324.
36. Broman, K. W. 2003. Mapping quantitative trait loci in the case of a spike in the phenotype distribution. Genetics 163: 1169-1175.
37. Broman, K. W., H. Wu, S. Sen, and G. A. Churchill. 2003. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
38. Zeller, R. 2001. Fixation, embedding, and sectioning of tissues, embryos, and single cells. Curr. Protoc. Mol. Biol. Chapter 14: Unit 14.1.
39. Lionakis, M. S., B. G. Fischer, J. K. Lim, M. Swamydas, W. Wan, C.-C. Richard Lee, J. I. Cohen, P. Scheinberg, J.-L. Gao, and P. M. Murphy. 2012. Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis. PLoS Pathog. 8: e1002865.
40. Mócsai, A., H. Zhang, Z. Jakus, J. Kitaura, T. Kawakami, and C. A. Lowell. 2003. G-protein-coupled receptor signaling in Syk-deficient neutrophils and mast cells. Blood 101: 4155-4163.
41. Underhill, D. M., E. Rossnagle, C. A. Lowell, and R. M. Simmons. 2005. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood 106: 2543-2550.
42. Ng, S.-L., B. A. Friedman, S. Schmid, J. Gertz, R. M. Myers, B. R. Tenoever, and T. Maniatis. 2011. IkB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses. Proc. Natl. Acad. Sci. USA 108: 21170-21175.
43. Barish, G. D., R. T. Yu, M. Karunasiri, C. B. Ocampo, J. Dixon, C. Benner, A. L. Dent, R. K. Tangirala, and R. M. Evans. 2010. Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev. 24: 2760-2765.
44. Romani, L., A. Mencacci, E. Cenci, G. Del Sero, F. Bistoni, and P. Puccetti. 1997. An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J. Immunol. 158: 2356-2362.
45. Huang, W., L. Na, P. L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190: 624-631.
46. Fleming, T. J., M. L. Fleming, and T. R. Malek. 1993. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151: 2399-2408.
47. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83: 64-70.
48. Hestdal, K., F. W. Ruscetti, J. N. Ihle, S. E. Jacobsen, C. M. Dubois, W. C. Kopp, D. L. Longo, and J. R. Keller. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147: 22-28.
49. Wang, J.-X., A. M. Bair, S. L. King, R. Shnayder, Y.-F. Huang, C.-C. Shieh, R. J. Soberman, R. C. Fuhlbrigge, and P. A. Nigrovic. 2012. Ly6G ligation blocks recruitment of neutrophils via a b2-integrin-dependent mechanism. Blood 120: 1489-1498.
50. Kannengiesser, C., B. Gérard, J. El Benna, D. Henri, Y. Kroviarski, S. Chollet-Martin, M.-A. Gougerot-Pocidalo, C. Elbim, and B. Grandchamp. 2008. Molecular epidemiology of chronic granulomatous disease in a series of 80 kindreds: identification of 31 novel mutations. Hum. Mutat. 29: E132-E149.
51. Auffray, C., M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
52. Serbina, N. V., and E. G. Pamer. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7: 311-317.
53. Ashman, R. B., J. M. Papadimitriou, A. Fulurija, K. E. Drysdale, C. S. Farah, O. Naidoo, and T. Gotjamanos. 2003. Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice. Microb. Pathog. 34: 103-113.
54. Rifkind, D., and J. A. Frey. 1972. Sex difference in antibody response of CFW mice to Candida albicans. Infect. Immun. 5: 695-698.
55. Baba, A., T. Fujita, and N. Tamura. 1984. Sexual dimorphism of the fifth component of mouse complement. J. Exp. Med. 160: 411-419.
56. Ashman, R. B., P. H. Kay, D. M. Lynch, and J. M. Papadimitriou. 1991. Murine candidiasis: sex differences in the severity of tissue lesions are not associated with levels of serum C3 and C5. Immunol. Cell Biol. 69: 7-10.
57. Chuang, K.-P., Y.-F. Huang, Y.-L. Hsu, H.-S. Liu, H.-C. Chen, and C.-C. Shieh. 2004. Ligation of lymphocyte function-associated antigen-1 on monocytes decreases very late antigen-4-mediated adhesion through a reactive oxygen species-dependent pathway. Blood 104: 4046-4053.
58. Sun, R., P. Iribarren, N. Zhang, Y. Zhou, W. Gong, E. H. Cho, S. Lockett, O. Chertov, F. Bednar, T. J. Rogers, et al. 2004. Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G proteincoupled formyl peptide receptor. J. Immunol. 173: 428-436.
59. Soehnlein, O., A. Zernecke, E. E. Eriksson, A. G. Rothfuchs, C. T. Pham, H. Herwald, K. Bidzhekov, M. E. Rottenberg, C. Weber, and L. Lindbom. 2008. Neutrophil secretion products pave the way for inflammatory monocytes. Blood 112: 1461-1471.
60. Soehnlein, O., E. Kenne, P. Rotzius, E. E. Eriksson, and L. Lindbom. 2008. Neutrophil secretion products regulate anti-bacterial activity in monocytes and macrophages. Clin. Exp. Immunol. 151: 139-145.
61. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
62. Ingersoll, M. A., R. Spanbroek, C. Lottaz, E. L. Gautier, M. Frankenberger, R. Hoffmann, R. Lang, M. Haniffa, M. Collin, F. Tacke, et al. 2010. Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115: e10-e19.
63. Lionakis, M. S., M. Swamydas, B. G. Fischer, T. S. Plantinga, M. D. Johnson, M. Jaeger, N. M. Green, A. Masedunskas, R. Weigert, C. Mikelis, et al. 2013. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J. Clin. Invest. 123: 5035-5051.
64. Osterholzer, J. J., G.-H. Chen, M. A. Olszewski, Y.-M. Zhang, J. L. Curtis, G. B. Huffnagle, and G. B. Toews. 2011. Chemokine receptor 2-mediated accumulation of fungicidal exudate macrophages in mice that clear cryptococcal lung infection. Am. J. Pathol. 178: 198-211.
65. Espinosa, V., A. Jhingran, O. Dutta, S. Kasahara, R. Donnelly, P. Du, J. Rosenfeld, I. Leiner, C.-C. Chen, Y. Ron, et al. 2014. Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLoS Pathog. 10: e1003940.
66. Boring, L., J. Gosling, S. W. Chensue, S. L. Kunkel, R. V. Farese, Jr., H. E. Broxmeyer, and I. F. Charo. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100: 2552-2561.
67. Mullick, A., Z. Leon, G. Min-Oo, J. Berghout, R. Lo, E. Daniels, and P. Gros. 2006. Cardiac failure in C5-deficient A/J mice after Candida albicans infection. Infect. Immun. 74: 4439-4451.
68. Laroque, A., G. Min-Oo, M. Tam, I. Radovanovic, M. M. Stevenson, and P. Gros. 2011. Genetic control of susceptibility to infection with Plasmodium chabaudi chabaudi AS in inbred mouse strains. Genes Immun. 13: 155-163.
69. Blankenhorn, E. P., G. Bryan, A. V. Kossenkov, L. D. Clark, X.-M. Zhang, C. Chang,W. Horng, L. S. Pletscher, J. M. Cheverud, L. C. Showe, and E. Heber-Katz. 2009. Genetic loci that regulate healing and regeneration in LG/J and SM/J mice. Mamm. Genome 20: 720-733.
70. Gantner, B. N., R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill. 2003. Collaborative induction of inflammatory responses by dectin-1 and Tolllike receptor 2. J. Exp. Med. 197: 1107-1117.
71. Brown, G. D., J. Herre, D. L. Williams, J. A. Willment, A. S. J. Marshall, and S. Gordon. 2003. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197: 1119-1124.
72. Balish, E., R. D. Wagner, A. Vázquez-Torres, C. Pierson, and T. Warner. 1998. Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice. J. Infect. Dis. 178: 478-487.
73. Cenci, E., A. Mencacci, G. Del Sero, C. F. d'Ostiani, P. Mosci, A. Bacci, C. Montagnoli, M. Kopf, and L. Romani. 1998. IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection. J. Immunol. 161: 3543-3550.
74. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584.
75. Xu, Q., and J. C. Reed. 1998. Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell 1: 337-346.
76. Lee, G.-H., H.-K. Kim, S.-W. Chae, D.-S. Kim, K.-C. Ha, M. Cuddy, C. Kress, J. C. Reed, H.-R. Kim, and H.-J. Chae. 2007. Bax inhibitor-1 regulates endoplasmic reticulum stress-associated reactive oxygen species and heme oxygenase-1 expression. J. Biol. Chem. 282: 21618-21628.
77. Kim, H.-R., G.-H. Lee, E. Y. Cho, S.-W. Chae, T. Ahn, and H.-J. Chae. 2009. Bax inhibitor 1 regulates ER-stress-induced ROS accumulation through the regulation of cytochrome P450 2E1. J. Cell Sci. 122: 1126-1133.
78. Chae, H.-J., H.-R. Kim, C. Xu, B. Bailly-Maitre, M. Krajewska, S. Krajewski, S. Banares, J. Cui, M. Digicaylioglu, N. Ke, et al. 2004. BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol. Cell 15: 355-366.
79. Dibbert, B., M. Weber, W. H. Nikolaizik, P. Vogt, M. H. Schöni, K. Blaser, and H. U. Simon. 1999. Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc. Natl. Acad. Sci. USA 96: 13330-13335.
80. Lauber, K., E. Bohn, S. M. Kröber, Y.-J. Xiao, S. G. Blumenthal, R. K. Lindemann, P. Marini, C. Wiedig, A. Zobywalski, S. Baksh, et al. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113: 717-730.
81. Lee, G.-H., T. Ahn, D.-S. Kim, S. J. Park, Y. C. Lee, W. H. Yoo, S. J. Jung, J.-S. Yang, S. Kim, A. Muhlrad, et al. 2010. Bax inhibitor 1 increases cell adhesion through actin polymerization: involvement of calcium and actin binding. Mol. Cell. Biol. 30: 1800-1813.
82. Weninger, W., M. Biro, and R. Jain. 2014. Leukocyte migration in the interstitial space of non-lymphoid organs. Nat. Rev. Immunol. 14: 232-246.
83. Holers, V. M., T. G. Ruff, D. L. Parks, J. A. McDonald, L. L. Ballard, and E. J. Brown. 1989. Molecular cloning of a murine fibronectin receptor and its expression during inflammation. Expression of VLA-5 is increased in activated peritoneal macrophages in a manner discordant from major histocompatibility complex class II. J. Exp. Med. 169: 1589-1605.
84. Johansson, S., G. Svineng, K. Wennerberg, A. Armulik, and L. Lohikangas. 1997. Fibronectin-integrin interactions. Front. Biosci. 2: d126-d146.
85. Burns, J. A., T. B. Issekutz, H. Yagita, and A. C. Issekutz. 2001. The alpha 4 beta 1 (very late antigen (VLA)-4, CD49d/CD29) and alpha 5 beta 1 (VLA-5, CD49e/CD29) integrins mediate beta 2 (CD11/CD18) integrin-independent neutrophil recruitment to endotoxin-induced lung inflammation. J. Immunol. 166: 4644-4649.
86. Sampaio, A. L. F., G. Zahn, G. Leoni, D. Vossmeyer, C. Christner, J. F. Marshall, and M. Perretti. 2010. Inflammation-dependent alpha 5 beta 1 (very late antigen-5) expression on leukocytes reveals a functional role for this integrin in acute peritonitis. J. Leukoc. Biol. 87: 877-884.
87. Lavigne, L. M., X. M. O'Brien, M. Kim, J. W. Janowski, J. E. Albina, and J. S. Reichner. 2007. Integrin engagement mediates the human polymorphonuclear leukocyte response to a fungal pathogen-associated molecular pattern. J. Immunol. 178: 7276-7282.
88. Berlin, C., E. L. Berg, M. J. Briskin, D. P. Andrew, P. J. Kilshaw, B. Holzmann, I. L. Weissman, A. Hamann, and E. C. Butcher. 1993. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74: 185-195.
89. Cepek, K. L., S. K. Shaw, C. M. Parker, G. J. Russell, J. S. Morrow, D. L. Rimm, and M. B. Brenner. 1994. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372: 190-193.
90. Wagner, R. D., A. Vazquez-Torres, J. Jones-Carson, T. Warner, and E. Balish. 1996. B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. J. Infect. Dis. 174: 589-597.
91. Tiisala, S., T. Paavonen, and R. Renkonen. 1995. Alpha E beta 7 and alpha 4 beta 7 integrins associated with intraepithelial and mucosal homing, are expressed on macrophages. Eur. J. Immunol. 25: 411-417.
92. Bungartz, G., S. Stiller, M. Bauer, W. Müller, A. Schippers, N. Wagner, R. Fässler, and C. Brakebusch. 2006. Adult murine hematopoiesis can proceed without beta1 and beta7 integrins. Blood 108: 1857-1864.
93. Calderwood, D. A., A. Huttenlocher, W. B. Kiosses, D. M. Rose, D. G. Woodside, M. A. Schwartz, and M. H. Ginsberg. 2001. Increased filamin binding to beta-integrin cytoplasmic domains inhibits cell migration. Nat. Cell Biol. 3: 1060-1068.